During the past decade, Pneumologicum Halle conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pneumologicum Halle" are "Pulmonary Disease, Chronic Obstructive" (2 trials). Many other conditions were trialed in "Pneumologicum Halle" in a lesser frequency.

Most popular intervention types in "Pneumologicum Halle" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist" (1 trials), "Spiolto® Respimat®" (1 trials) and "Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pneumologicum Halle" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pneumologicum Halle". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pneumologicum Halle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pneumologicum Halle, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".